Highlights Aethlon Medical, Inc.

Equities

AEMD

US00808Y4061

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.36 ^USD	-9.51%		-6.85%	-37.90%

Feb. 14	Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 14	Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	23-10-10	CI
Reverse Split: 1 of 10	23-10-04	FA
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split	23-10-04	MT
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-28	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Aethlon Medical Taps Namsa to Manage Planned Clinical Trial of Medical Device for Cancer	23-01-30	MT
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Aethlon Medical, Inc. Announces Early Feasibility Study of the Hemopurifier	22-09-29	CI
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Aethlon Medical, Inc. Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment	22-07-11	CI
Aethlon Medical Posts Wider Loss, Lower Revenue for Full-Year Fiscal 2022	22-06-28	MT
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-28	CI
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants	22-05-02	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Aethlon Medical Pares Fiscal Q3 Loss per Share as Revenue Plunges	22-02-14	MT
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-09	CI
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aethlon Medical, Inc.

Equities

AEMD

US00808Y4061

Highlights

Filters